Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors

Atherosclerosis

Volumn 210, Issue 1, 2010, Pages 232-236

  Akishita, Masahiro ^a   Hashimoto, Masayoshi ^b   Ohike, Yumiko ^a   Ogawa, Sumito ^a   Iijima, Katsuya ^a   Eto, Masato ^a   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Androgen; Estrogen; Risk factor; Sex hormone

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ESTRADIOL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG USE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TESTOSTERONE BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TESTOSTERONE;

EID: 77952427354     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.037     Document Type: Article

References (27)

1. Muller M., den Tonkelaar I., Thijssen J.H., Grobbee D.E., van der Schouw Y.T. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003, 149:583-589.
2. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005, 26:833-876.
3. Fukai S., Akishita M., Yamada S., et al. Association of plasma sex hormone levels with functional decline in elderly men and women. Geriatr Gerontol Int 2009, 9:282-289.
4. Hak A.E., Witteman J.C., de Jong F.H., et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002, 87:3632-3639.
5. Simon D., Charles M.A., Nahoul K., et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 1997, 82:682-685.
6. Fogari R., Preti P., Zoppi A., et al. Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res 2005, 28:625-630.
7. Stellato R.K., Feldman H.A., Hamdy O., Horton E.S., McKinlay J.B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000, 23:490-494.
8. Akishita M., Hashimoto M., Ohike Y., et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 2007, 30:1029-1034.
9. van den Beld A.W., Bots M.L., Janssen J.A., et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003, 157:25-31.
10. Shores M.M., Matsumoto A.M., Sloan K.L., Kivlahan D.R. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006, 166:1660-1665.
11. Khaw K.T., Dowsett M., Folkerd E., et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007, 116:2694-2701.
12. Laughlin G.A., Barrett-Connor E., Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008, 93:68-75.
13. Ogihara T., Kikuchi K., Matsuoka H., et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009, 32:3-107.
14. Teramoto T., Sasaki J., Ueshima H., et al. Japan Atherosclerosis Society (JAS) Committee for epidemiology and clinical management of atherosclerosis. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007, 14:155-158.
15. Kuzuya T., Nakagawa S., Satoh J., et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85.
16. Kobayashi K., Akishita M., Yu W., et al. Interrelationship between non-invasive measurements of atherosclerosis; flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004, 173:13-18.
17. Feldman H.A., Johannes C.B., McKinlay J.B., Longcope C. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann Epidemiol 1998, 8:217-228.
18. Jeppesen L.L., Jorgensen H.S., Nakayama H., et al. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol 1996, 16:749-754.
19. Araujo A.B., Kupelian V., Page S.T., et al. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007, 167:1252-1260.
20. Smith G.D., Ben-Shlomo Y., Beswick A., et al. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 2005, 112:332-340.
21. Feldman H.A., Johannes C.B., Araujo A.B., et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2001, 153:79-89.
22. Arnlov J., Pencina M.J., Amin S., et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 2006, 145:176-184.
23. Emmelot-Vonk M.H., Verhaar H.J., Nakhai Pour H.R., et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008, 299:39-52.
24. Ong P.J., Patrizi G., Chong W.C., et al. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 2000, 85:269-272.
25. Tharp D.L., Masseau I., Ivey J., Ganjam V.K., Bowles D.K. Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine. Cardiovasc Res 2009, 82:152-160.
26. Jones T.H., Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009 April 24, [Epub ahead of print].
27. Fogari R., Preti P., Derosa G., et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002, 58:177-180.